IL2rg Cytokines Enhance Umbilical Cord Blood CD34+ Cells Differentiation to T Cells

Zeynab Aliyari ^1,2, Sara Soleimanirad ³, Manizheh Sayyah Melli ³, Hamid Tayefi Nasrabadi ⁴, Hojjatollah Nozad Charoudeh ^1,4 *

Cited by CrossRef: 4

1- Brazvan B, Ebrahimi-Kalan A, Velaei K, Mehdipour A, Aliyari serej Z, Ebrahimi A, Ghorbani M, Cheraghi O, Nozad Charoudeh H. Telomerase activity and telomere on stem progeny senescence. Biomedicine & Pharmacotherapy. 2018;102:9 [Crossref]

2- Zhao Y, Liu P, Xin Z, Shi C, Bai Y, Sun X, Zhao Y, Wang X, Liu L, Zhao X, Chen Z, Zhang H. Biological Characteristics of Severe Combined Immunodeficient Mice Produced by CRISPR/Cas9-Mediated Rag2 and IL2rg Mutation. Front Genet. 2019;10 [Crossref]

3- Mehdipour A, Ebrahimi A, Shiri-Shahsavar M, Soleimani-Rad J, Roshangar L, Samiei M, Ebrahimi-Kalan A. The potentials of umbilical cord-derived mesenchymal stem cells in the treatment of multiple sclerosis. 2019;30(8):857 [Crossref]

4- Hu F, Zhu Y, Tian J, Xu H, Xue Q. Single-Cell Sequencing Combined with Transcriptome Sequencing Constructs a Predictive Model of Key Genes in Multiple Sclerosis and Explores Molecular Mechanisms Related to Cellular Communication. JIR. 2024;Volume 17:191 [Crossref]